Clinical Trial Update: Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a fixed-dose combination of bempedoic acid and ezetimibe in patients with type 2 diabetes and elevated LDL-C has completed; results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia
• Hyperlipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• Bempedoic acid + ezetimibe fixed-dose combination (bempedoic acid + ezetimibe)

Snippet

Sponsor: Esperion Therapeutics, Inc. | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2020-04-09